| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Nanjing Well Pharmaceutical Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥20.25 |
| 52 Week High | CN¥27.88 |
| 52 Week Low | CN¥17.65 |
| Beta | 0.37 |
| 11 Month Change | 2.12% |
| 3 Month Change | -14.30% |
| 1 Year Change | -19.10% |
| 33 Year Change | 8.81% |
| 5 Year Change | -17.71% |
| Change since IPO | -22.36% |
Recent News & Updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06Recent updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06Shareholder Returns
| 603351 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 0.7% | -2.7% | -2.3% |
| 1Y | -19.1% | -26.2% | -17.3% |
Return vs Industry: 603351 exceeded the CN Chemicals industry which returned -26.2% over the past year.
Return vs Market: 603351 underperformed the CN Market which returned -17.3% over the past year.
Price Volatility
| 603351 volatility | |
|---|---|
| 603351 Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 5.2% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 603351 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603351's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 673 | Renrong Wu | www.well-js.com |
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables.
Nanjing Well Pharmaceutical Group Co.,Ltd. Fundamentals Summary
| 603351 fundamental statistics | |
|---|---|
| Market cap | CN¥2.74b |
| Earnings (TTM) | CN¥137.71m |
| Revenue (TTM) | CN¥1.32b |
19.9x
P/E Ratio2.1x
P/S RatioIs 603351 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603351 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.32b |
| Cost of Revenue | CN¥977.23m |
| Gross Profit | CN¥343.80m |
| Other Expenses | CN¥206.09m |
| Earnings | CN¥137.71m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.02 |
| Gross Margin | 26.03% |
| Net Profit Margin | 10.42% |
| Debt/Equity Ratio | 30.9% |
How did 603351 perform over the long term?
See historical performance and comparison